Venus Remedies rises on the BSE

Venus Remedies Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 526953 | NSE: VENUSREM

14 Dec 2011 Evaluate

Venus Remedies is currently trading at Rs 166.80, up by 0.95 points or 0.57% from its previous closing of Rs 165.85 on the BSE.

The scrip opened at Rs 166.00 and has touched a high and low of Rs 167.90 and Rs 164.25 respectively.

The BSE group 'B' stock of face value Rs 10 has touched a 52 week high of Rs 293.95 on 06-Jan-2011 and a 52 week low of Rs 162.00 on 13-Dec-2011.

Last one week high and low of the scrip stood at Rs 170.00 and Rs 162.00 respectively. The current market cap of the company is Rs 151.62 crore.

The promoters holding in the company stood at 30.42% while Institutions and Non-Institutions held 16.35% and 53.23% respectively.

Venus Remedies has been adjudged winner of Emerging Company of the year 2011 in the 4th annual Pharmaceutical Leadership Summit & Award 2011.The company won the award among five nominated for this particular award category.

Other than this there were 24 other categories for which various companies have been awarded. Pharmaceutical Leadership Summit & Award 2011 is Asia’s leading and prestigious summit presented and organized by India’s leading pharma bi monthly pharma leaders in association with Indo American Chamber of Commerce (IACC), delivering innovative, fully integrated and collaborative approaches to next generation leadership issues.

Recently, Venus Remedies has emerged as a winner of silver certificate of merit in the Economic Times' India Manufacturing Excellence Awards (IMEA), 2011 held in Mumbai. The company has bagged this award for its Baddi unit, based on the assessments conducted at the site and whetted by the jury of Economic Times' IMEA 2011 in partnership with Frost & Sullivan.

Venus Remedies Share Price

955.00 -23.75 (-2.43%)

05-May-2026 14:28 View Price Chart

Peers

Company Name	CMP
Sun Pharma Inds.	1813.15
Dr. Reddys Lab	1274.70
Cipla	1330.10
Zydus Lifesciences	910.05
Lupin	2344.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.